UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 225

Sortiert nach

Changes in breast cancer management during the Corona Virus Disease 19 pandemic: An international survey of the European Breast Cancer Research Association of Surgical Trialists (EUBREAST)

Breast (Edinburgh), 2020-08, Vol.52, p.110-115

2020

Volltextzugriff (PDF)

Treatment of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: German Expert Opinions on the 17th International St. Gallen Consensus Conference

Geburtshilfe und Frauenheilkunde, 2021-06, Vol.81 (6), p.637-653

2021

Volltextzugriff (PDF)

New treatment options for hormone receptor positive breast cancer in 2023

Current opinion in obstetrics & gynecology, 2023-02, Vol.35 (1), p.62

Lüftner, Diana

2023

Volltextzugriff (PDF)

Systemic therapy of metastatic breast cancer: a plea for confirmation of subtypes by genomic assays

Journal of cancer research and clinical oncology, 2022-06, Vol.148 (6), p.1275-1276

Lüftner, Diana

2022

Volltextzugriff (PDF)

Approval by Authorities Does Not Allow For Suboptimal Study Conduct but Offers New Academic Possibilities

Breast care (Basel, Switzerland), 2019-03, Vol.14 (1), p.2-3

Lüftner, Diana

2019

Volltextzugriff (PDF)

Clinical Practice Guidelines for Breast Cancer: Current Limitations

The breast journal, 2015-07, Vol.21 (4), p.450-453

Lüftner, Diana

2015

Volltextzugriff (PDF)

What Does the Pipeline Promise about Upcoming Biosimilar Antibodies in Oncology?

Breast care (Basel, Switzerland), 2019-03, Vol.14 (1), p.10-16

2019

Volltextzugriff (PDF)

How detection of immune-related adverse events fails during transfer of patients between medical sectors

Journal of cancer research and clinical oncology, 2023-11, Vol.149 (15), p.14465-14470

2023

Volltextzugriff (PDF)

Three-year follow-up from a phase 3 study of SB3 (a trastuzumab biosimilar) versus reference trastuzumab in the neoadjuvant setting for human epidermal growth factor receptor 2–positive breast cancer

European journal of cancer (1990), 2019-10, Vol.120, p.1-9

2019

Volltextzugriff (PDF)

New Therapeutic Strategies in Advanced Nonoperable or Metastatic HER2-positive Breast Cancer

Geburtshilfe und Frauenheilkunde, 2021-06, Vol.81 (6), p.666-678

2021

Volltextzugriff (PDF)

What do hematologists and oncologists consider necessary for their career? Results of an online survey in Germany, Austria and Switzerland

Journal of cancer research and clinical oncology, 2023-07, Vol.149 (8), p.5331-5344

2023

Volltextzugriff (PDF)

Abstract P2-13-05: Central nervous system metastases as a site of first recurrence in adjuvant therapy trials of HER2+ early breast cancer (EBC)

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P2-P2-13-05

2022

Volltextzugriff (PDF)

Breast cancer and bone metastases: a call for appropriate treatment

Supportive care in cancer, 2016-10, Vol.24 (10), p.4075-4077

2016

Volltextzugriff (PDF)

Onco-Cardiology: Consensus Paper of the German Cardiac Society, the German Society for Pediatric Cardiology and Congenital Heart Defects and the German Society for Hematology and Medical Oncology

Clinical research in cardiology, 2020-10, Vol.109 (10), p.1197-1222

2020

Volltextzugriff (PDF)

Neratinib as extended adjuvant therapy in patients with copositive early breast cancer: German health technology assessment–driven analyses from the ExteNET study

European journal of cancer (1990), 2021-06, Vol.150, p.268-277

2021

Volltextzugriff (PDF)

Therapeutic approaches for protecting bone health in patients with breast cancer

Breast (Edinburgh), 2018-02, Vol.37, p.28-35

2018

Volltextzugriff (PDF)

Management of Metastatic Bone Disease Algorithms for Diagnostics and Treatment

Anticancer research, 2016-06, Vol.36 (6), p.2631-2637

2016

Volltextzugriff (PDF)

Efficacy and safety of everolimus plus exemestane in patients with hormone receptor-positive, HER-2-negative advanced breast cancer: Results from the open-label, multicentre, non-interventional BRAWO study

International journal of cancer, 2024-07, Vol.155 (1), p.128-138

2024

Volltextzugriff (PDF)

Efficacy, safety, and prognosis prediction in patients treated with ribociclib in combination with letrozole: Final results of phase 3b RIBECCA study in hormone receptor positive, human epidermal growth factor receptor-2 negative, locally advanced or metastatic breast cancer

European journal of cancer (1990), 2024-02, Vol.198, p.113480-113480, Article 113480

2024

Volltextzugriff (PDF)

Mutations in BRCA1/2 and Other Panel Genes in Patients With Metastatic Breast Cancer -Association With Patient and Disease Characteristics and Effect on Prognosis

Journal of clinical oncology, 2021-05, Vol.39 (15), p.1619-1630

2021

Volltextzugriff (PDF)

Prophylaxis of Neutropenia with Lipegfilgrastim in Breast Cancer Patients with Dose-Dense Chemotherapy: Results of a Noninterventional Study on Therapeutic Routine in Germany (NADENS)

Breast care (Basel, Switzerland), 2022-10, Vol.17 (5), p.508-513

2022

Volltextzugriff (PDF)

Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor‐positive, human epidermal growth factor receptor 2‐negative locally advanced or metastatic breast cancer: Results of the single‐arm, phase IIIB 4EVER trial

International journal of cancer, 2019-02, Vol.144 (4), p.877-885

2019

Volltextzugriff (PDF)

Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancer

Cancer treatment reviews, 2022-12, Vol.111, p.102468-102468, Article 102468

2022

Volltextzugriff (PDF)

Healthcare resource utilisation associated with skeletal‐related events in European patients with multiple myeloma: Results from a prospective, multinational, observational study

European journal of haematology, 2018-05, Vol.100 (5), p.479-487

2018

Volltextzugriff (PDF)

1 – 25 von 225

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(195)
Mit Volltextzugriff
(203)

Publikationsform

Sprache

Englisch
(132)
Deutsch
(112)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(4)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Changes in breast cancer management during the Corona Virus Disease 19 pandemic: An international survey of the European Breast Cancer Research Association of Surgical Trialists (EUBREAST)

Treatment of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: German Expert Opinions on the 17th International St. Gallen Consensus Conference

New treatment options for hormone receptor positive breast cancer in 2023

Systemic therapy of metastatic breast cancer: a plea for confirmation of subtypes by genomic assays

Approval by Authorities Does Not Allow For Suboptimal Study Conduct but Offers New Academic Possibilities

Clinical Practice Guidelines for Breast Cancer: Current Limitations

What Does the Pipeline Promise about Upcoming Biosimilar Antibodies in Oncology?

How detection of immune-related adverse events fails during transfer of patients between medical sectors

Three-year follow-up from a phase 3 study of SB3 (a trastuzumab biosimilar) versus reference trastuzumab in the neoadjuvant setting for human epidermal growth factor receptor 2–positive breast cancer

New Therapeutic Strategies in Advanced Nonoperable or Metastatic HER2-positive Breast Cancer

What do hematologists and oncologists consider necessary for their career? Results of an online survey in Germany, Austria and Switzerland

Abstract P2-13-05: Central nervous system metastases as a site of first recurrence in adjuvant therapy trials of HER2+ early breast cancer (EBC)

Breast cancer and bone metastases: a call for appropriate treatment

Onco-Cardiology: Consensus Paper of the German Cardiac Society, the German Society for Pediatric Cardiology and Congenital Heart Defects and the German Society for Hematology and Medical Oncology

Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status

Neratinib as extended adjuvant therapy in patients with copositive early breast cancer: German health technology assessment–driven analyses from the ExteNET study

Therapeutic approaches for protecting bone health in patients with breast cancer

Management of Metastatic Bone Disease Algorithms for Diagnostics and Treatment

Efficacy and safety of everolimus plus exemestane in patients with hormone receptor-positive, HER-2-negative advanced breast cancer: Results from the open-label, multicentre, non-interventional BRAWO study

Efficacy, safety, and prognosis prediction in patients treated with ribociclib in combination with letrozole: Final results of phase 3b RIBECCA study in hormone receptor positive, human epidermal growth factor receptor-2 negative, locally advanced or metastatic breast cancer

Mutations in BRCA1/2 and Other Panel Genes in Patients With Metastatic Breast Cancer -Association With Patient and Disease Characteristics and Effect on Prognosis

Prophylaxis of Neutropenia with Lipegfilgrastim in Breast Cancer Patients with Dose-Dense Chemotherapy: Results of a Noninterventional Study on Therapeutic Routine in Germany (NADENS)

Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor‐positive, human epidermal growth factor receptor 2‐negative locally advanced or metastatic breast cancer: Results of the single‐arm, phase IIIB 4EVER trial

Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancer

Healthcare resource utilisation associated with skeletal‐related events in European patients with multiple myeloma: Results from a prospective, multinational, observational study

Suchergebnisse filtern